Advertisement
The Central Drug Standard Control Organisation has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are the Serum Institute of India (SII) and the Gennova Biopharmaceuticals.
“We have received a confirmation about PM Modi’s visit to the Serum Institute of India on Saturday, but his minute-to -minute program is yet to be received,” Pune Divisional Commissioner Saurabh Rao told news agency Press Trust of India.
On Tuesday, Rao said there was a possibility of the PM’s visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.
Related Articles
Advertisement
Serum Institute of India is the world’s largest vaccine manufacturer by number of doses produced and sold globally.